HK's Jacobson Pharma at near 16-mths high on new product launch

Jacobson Pharma

06/02/2020 02:46

** Shares of Jacobson Pharma Corp Ltd  2633.HK  rise as much
as 8.5% to HK$1.79, highest since October 2018
    ** Hong Kong-based generic drugs maker says its unit has
launched a home diagnostic product for influenza and respiratory
syncytial virus across major healthcare chain stores and drug
stores in Hong Kong and Macau  urn:newsml:reuters.com:*:nFWN2A50EI
    ** Company says the product is one-step home diagnostic test
designed for determination of specific types of influenza A and
B virus and respiratory syncytial virus with test results
available in 8 minutes
    ** As of previous close, stock had slid 4.1% so far this
year
    ** Jacobson Pharma has outperformed the Hang Seng Commerce &
Industry index  .HSNC  by 0.4 percentage points in the past one
month
    ** The Hong Kong benchmark index  .HSI  rises 1.4%

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)